UK firm eyes neuroblastoma blood test partners
This article was originally published in Clinica
Executive Summary
UK firm Proteome Sciences is looking for partners to co-develop and commercialise new diagnostic and prognostic blood tests for neuroblastoma, a cancer of the sympathetic nervous system.